Micromet To Report Fourth Quarter and Full Year 2009 Financial Results on March 4

BETHESDA, Md.,, Feb. 25 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) today announced that it will host a conference call and audio webcast to review its fourth quarter and full year 2009 results on Thursday, March 4, 2010, at 8:30 AM ET.

To participate in the conference call, please dial 800-659-1942 (domestic) or 617-614-2710 (international) and reference the access code 85243244.  The presentation will be available via webcast at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=197259&eventID=2770538.

A replay of the call will be available from 11:30 AM ET on March 4, 2010 until midnight on April 4, 2010. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and reference the access code 93754122.  The archived webcast will be available for 30 days in the Investor Relations section of the Micromet website at www.micromet-inc.com.  

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of antibody-based therapies for the treatment of cancer. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® technology, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including sanofi-aventis, Bayer Schering Pharma, Merck Serono, MedImmune and Nycomed. Additional information can be found at www.micromet-inc.com.

SOURCE Micromet, Inc.